Gad Soffer, Chief Operating Officer at Atara Biotherapeutics, Inc. (ATRA), sold 16,718 shares at $20.55 ($334K) on 2016-11-14, disclosed to the SEC on 2016-11-16.
Open-market sale of $334k ATRA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.55 | 9,582 | $197K | 58.9% |
| 2 | $19.27 | 7,136 | $138K | 41.1% |
| Total | $20.00 avg | 16,718 | $334K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |